“To provide for research and education with respect to triple-negative breast cancer, and for other purposes.”
No CRS summary available for this bill.
This section states congressional findings on breast cancer, including that it accounts for 1 in 4 cancer diagnoses among U.S. women; survival rates are 90% for White women and 78% for African-American women; early detection yields a 98% five-year survival rate (versus 23% for stage IV); triple-negative breast cancer affects 10-20% of patients (higher prevalence indicated by studies), is most common in African-American women (who are three times more likely than White women to develop it) followed by Hispanic women, grows quickly, lacks effective targeted therapies, and requires early detection; and current research lacks adequate data on its prevalence/incidence, treatment costs, and prevention/cure methods among minority women.
This section establishes a new section 417B within the National Cancer Institute's programs (42 U.S.C. 285 et seq.) addressing triple-negative breast cancer, an aggressive subtype lacking common receptors for targeted therapies and disproportionately affecting minority women. Specifically, the section (1) directs the NIH Director to expand, intensify, and coordinate research through specified institutes—including the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Environmental Health Sciences, Office of Research on Women’s Health, and National Institute on Minority Health and Health Disparities—with coordination by the Office of Research on Women’s Health, authorizing such sums as necessary for FY2026 through 2031; (2) directs the HHS Secretary, acting through the CDC Director, to develop and disseminate public information on its incidence and prevalence (including elevated risks for minority women) and available treatments, authorizing such sums as necessary for FY2026 through 2031; and (3) directs the HHS Secretary, acting through the HRSA Administrator, to disseminate information to health care providers on such risks and treatments, authorizing such sums as necessary for FY2026 through 2031. The section defines "minority women" as members of a racial or ethnic minority group, as defined in section 1707(g) of the Public Health Service Act.